Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
June 4, 2026
A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis
Chang Wang, Chi Yan, Qinduo Ren, et al.
Cancer Communications (London, England)
|
January 18, 2025
Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial
Jianli Ma, Jingxuan Wang, Ting Xu, et al.
Eclinicalmedicine
|
January 27, 2025
Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021
Linna Yuan, Junxian Tao, Jiacheng Wang, et al.
Expert Review of Anticancer Therapy
|
September 1, 2025
Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021
Yuan Xu, Ruilin Li, Ning Wang, et al.
Biomarker Research
|
March 25, 2025
Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021
Yingnan Ma, Haiyan Chen, Wenhua Lv, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 12, 2021
Ten Years of EWAS
Siyu Wei, Junxian Tao, Jing Xu, et al.
Gynecologic Oncology
|
October 24, 2024
Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer
Guiling Li, Xiaofan Li, Rutie Yin, et al.
Frontiers in Immunology
|
July 30, 2025
Plasma proteomics-based risk scores for psoriasis prediction: a novel approach to early diagnosis
Siyu Wei, Zehong Yue, Chen Sun, et al.
JAMA Oncology
|
June 4, 2026
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial
Jingjing Liu, Liang Han, Lin Wu, et al.
JAMA
|
September 27, 2022
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
Ying Cheng, Liang Han, Lin Wu, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
June 4, 2026
A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis
Chang Wang, Chi Yan, Qinduo Ren, et al.
Cancer Communications (London, England)
|
January 18, 2025
Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial
Jianli Ma, Jingxuan Wang, Ting Xu, et al.
Eclinicalmedicine
|
January 27, 2025
Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021
Linna Yuan, Junxian Tao, Jiacheng Wang, et al.
Expert Review of Anticancer Therapy
|
September 1, 2025
Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021
Yuan Xu, Ruilin Li, Ning Wang, et al.
Biomarker Research
|
March 25, 2025
Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021
Yingnan Ma, Haiyan Chen, Wenhua Lv, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 12, 2021
Ten Years of EWAS
Siyu Wei, Junxian Tao, Jing Xu, et al.
Gynecologic Oncology
|
October 24, 2024
Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer
Guiling Li, Xiaofan Li, Rutie Yin, et al.
Frontiers in Immunology
|
July 30, 2025
Plasma proteomics-based risk scores for psoriasis prediction: a novel approach to early diagnosis
Siyu Wei, Zehong Yue, Chen Sun, et al.
JAMA Oncology
|
June 4, 2026
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial
Jingjing Liu, Liang Han, Lin Wu, et al.
JAMA
|
September 27, 2022
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
Ying Cheng, Liang Han, Lin Wu, et al.
Page
of 23